Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Effect of Azithromycin on Oesophageal Hypomotility [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the effect of azithromycin on esophageal motility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: JAFAR JAFARI | Conditions: Esophageal Motility Disorders | Phase 2 | Status: COMPLETED